Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Improvement of hemoglobin levels after a switch from intravenous to subcutaneous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space.
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
Prevalence of anti-SOX1 reactivity in various neurological disorders.
The experience of transitioning from relapsing remitting to secondary progressive multiple sclerosis: views of patients and health professionals.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Brain stiffness increases with myelin content.
An oral NaV1.8 blocker improves motor function in mice completely deficient of myelin protein P0.
Between genetics and biology. Is ENMG useful in peripheral neuropathy diagnosis and management?
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions.
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
[Multiple Sclerosis and Commensal Gut Flora].
Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis.
Diagnosis and Management of Multiple Sclerosis in Children.
Structural Alterations of Segmented Macular Inner Layers in Aquaporin4-Antibody-Positive Optic Neuritis Patients in a Chinese Population.
Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
Knockdown of Unconventional Myosin ID Expression Induced Morphological Change in Oligodendrocytes.
Nanoparticles restore lysosomal acidification defects: Implication for Parkinson and other lysosomal-related diseases.
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis.
The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis.
Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program.
A framework for optimal whole-sample histological quantification of neurite orientation dispersion in the human spinal cord.
Pages
« first
‹ previous
…
777
778
779
780
781
782
783
784
785
…
next ›
last »